Literature DB >> 21576826

Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.

Zbynek Strasky1, Lenka Vecerova, Jana Rathouska, Martina Slanarova, Eva Brcakova, Zdenka Kudlackova, Ctirad Andrys, Stanislav Micuda, Petr Nachtigal.   

Abstract

BACKGROUND: The aim of the study was to evaluate whether cholesterol-rich diet affects transforming growth factor-β-RIII (endoglin) levels in blood and 2 endoglin-related pathways in the aorta of ApoE/LDLR double knockout mice. METHODS AND
RESULTS: Mice were fed either chow diet (CHOW) (n=8) or by 1% cholesterol-rich diet (CHOL) (n=8). Biochemical analysis of cholesterol and endoglin levels in blood, lesion size area, immunohistochemistry and Western blot analysis in mice aortas were performed. Biochemical analysis showed that cholesterol-rich diet resulted in a significant increase of cholesterol and endoglin levels in serum, and increased plaque size in the aorta. In addition, a cholesterol-rich diet significantly decreased the expressions of endoglin by 92%, activin receptor-like kinase (ALK)-1 by 71%, p-Smad2 by 21%, and vascular endothelial growth factor (VEGF) by 37% when compared to CHOW mice, but ALK-5, p-Smad1, and endothelial nitric oxide synthase were not significantly affected.
CONCLUSIONS: Hypercholesterolemia increases endoglin levels in blood and simultaneously decreases its expression in aorta, together with atherosclerosis protective markers p-Smad2 and VEGF, followed by increased plaque size. Inhibition of endoglin signaling might be one of the mechanisms responsible for the promoting of endothelial dysfunction and atherogenesis. Moreover, the monitoring of endoglin serum levels might represent an attractive blood marker of progression of disease; however, the precise source and role of endoglin in blood serum remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576826     DOI: 10.1253/circj.cj-10-1285

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients.

Authors:  J Víšek; M Bláha; V Bláha; M Lášticová; M Lánska; C Andrýs; J Duintjer Tebbens; Ivone Cristina Igreja E Sá; K Tripská; M Vicen; I Najmanová; P Nachtigal
Journal:  Orphanet J Rare Dis       Date:  2021-02-27       Impact factor: 4.123

2.  Immature Vascular Smooth Muscle Cells in Healthy Murine Arteries and Atherosclerotic Plaques: Localization and Activity.

Authors:  Alexander Balatskiy; Ilia Ozhimalov; Maria Balatskaya; Alexandra Savina; Julia Filatova; Natalia Kalinina; Vladimir Popov; Vsevolod Tkachuk
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

3.  High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta.

Authors:  Ivana Nemeckova; Agnieszka Serwadczak; Barbara Oujo; Katerina Jezkova; Jana Rathouska; Petra Fikrova; Michala Varejckova; Carmelo Bernabeu; Jose M Lopez-Novoa; Stefan Chlopicki; Petr Nachtigal
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

4.  Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.

Authors:  Sylwia Wasiak; Dean Gilham; Laura M Tsujikawa; Christopher Halliday; Karen Norek; Reena G Patel; Kevin G McLure; Peter R Young; Allan Gordon; Ewelina Kulikowski; Jan Johansson; Michael Sweeney; Norman C Wong
Journal:  Data Brief       Date:  2016-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.